Delivery of Care provides insight on changes in delivery of care in the next three years so you can anticipate the evolving access opportunities and risks for your company’s brands.

Drug Management Tactics provides insight on changes in stakeholder management of medical and pharmacy benefit products across therapeutic markets in the next three years so you can anticipate the evolving access opportunities and risks for your company’s brands.

Evolution of the Global Biosimilars Market assesses the use and impact of biosimilar entrants across markets so you can identify opportunities for your product as the market evolves.

Evolution of the Global Biosimilars Market answers your questions so you can identify opportunities and risks for your brand.

  • Implications for the U.S. market from experience in Europe
  • Payer attitudes to access and defense tactics employed by manufacturers
  • Best practice implications for market access by originator and biosimilar entrants

Insurance and Benefit Design provides insight on changes in insurance and benefit design in the next three years so you can anticipate the evolving access opportunities and risks for your company’s brands.

Market Access Macrotrends answers your questions about changes in the access environment related to:

  • Current and emerging U.S. access trends
  • Response by stakeholders to market access trends
  • Changes to the access landscape over time

Medicare and Medicaid Policy Impact assesses effects legislative or regulatory policy proposals may have on the healthcare access landscape.

Medicare and Medicaid Policy Impact answers your questions about government programmatic changes, including:

  • New Medicare Part D plan flexibilities
  • Implications of rebates changes to Medicare, Medicaid, and commercial businesses
  • Medicaid state waiver program
  • Potential outcomes of policy changes

Medicare and Medicaid Policy Impact answers your questions about government programmatic changes, including:

  • New Medicare Part D plan flexibilities
  • Implications of rebates changes to Medicare, Medicaid, and commercial businesses
  • Medicaid state waiver program
  • Potential outcomes of policy changes

Value, Quality, and Reimbursement provides insight on changes in value assessments, quality initiatives,and provider reimbursement in the next three years so you can anticipate the evolving access opportunities and risks for your company’s brands.

Your search yielded no results

Search

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.